The Board of Director has approved Audited Standalone and Consolidated Financial Result for the year ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kemistar Corporation's Board approved audited results for FY25. On a consolidated basis, revenue from operations jumped to Rs. 1,814.20 lakhs from Rs. 1,107.05 lakhs in FY24 — a growth of about 64% — driven mainly by its wholly owned subsidiary K.P. International (which contributed Rs. 1,581 lakhs in revenue and Rs. 48.75 lakhs in profit). However, consolidated profit after tax grew only modestly to Rs. 60.10 lakhs vs Rs. 53.11 lakhs (about 13%), and profit before tax margin actually shrank from 6.5% to 3.9%, indicating margin compression despite top-line growth. On a standalone basis, the picture is weaker: revenue fell to Rs. 304.67 lakhs from Rs. 420.51 lakhs (down ~28%) and PAT nearly halved to Rs. 11.36 lakhs, with Q4 standalone slipping into a Rs. 4.60 lakh loss. Auditor N.S. Nanavati & Co. issued an unmodified (clean) opinion on both sets of results. The Board also appointed Rohit Periwal & Associates as Secretarial Auditor for five years and Ms. Aesha Mashru as Internal Auditor for FY26.
Short-term: A clean audit opinion and strong consolidated revenue growth are positives, but weak standalone numbers, shrinking margins, and negative Q4 standalone profit could weigh on investor sentiment. The company appears increasingly dependent on its subsidiary for earnings, so investors should watch subsidiary-level performance closely going forward.